...
首页> 外文期刊>International journal of hematology >CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: application for MRD detection in leukemia patients.
【24h】

CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: application for MRD detection in leukemia patients.

机译:通过八色流式细胞术在骨髓和外周血干细胞集合中检测到的CD34 +细胞亚群:在白血病患者中进行MRD检测的应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fast development in polychromatic flow cytometry (PFC) makes it possible to study CD34+ cells with two scatter and eight fluorescence parameters. Minimal residual disease (MRD) is determined as persistence of leukemic cells at submicroscopic levels in bone marrow (BM) of patients in complete remission. MRD can be present in collections of hematopoietic stem cell from blood (HSC-B). Using PFC, we have defined patterns of antigen expression in CD34+ cell subpopulations in BM and applied them as templates in MRD analysis. Twelve BM samples from hospital control (HC) patients with no signs of hematological malignancy were studied using five 8-color monoclonal antibody combinations detecting subsets of CD34+ cells. These patterns have been used as templates to determine levels of MRD in HSC-B collections from six AML patients. Several subsets of CD34+ precursor cells were found to be present at very low frequencies (<10(-4)) in BM and/or HSC-B collections. All six HSC-B collections from AML patients showed MRD by 8-color technique and only three by previously applied 3-color method. The 8-color technique showed promising results in efficient detection of different CD34+ subpopulations of HSC-B and in MRD quantification. Monitoring of MRD should become a part of quality control of HSC-B collections.
机译:多色流式细胞术(PFC)的快速发展使研究具有两个散射和八个荧光参数的CD34 +细胞成为可能。最小残留疾病(MRD)被确定为完全缓解后患者骨髓(BM)中亚显微水平的白血病细胞持续存在。 MRD可能存在于血液中造血干细胞的集合中(HSC-B)。使用PFC,我们已经定义了BM中CD34 +细胞亚群中抗原表达的模式,并将其用作MRD分析中的模板。使用五个检测CD34 +细胞子集的8色单克隆抗体组合研究了十二份BM样本,这些样本来自医院对照(HC)没有血液恶性肿瘤的迹象。这些模式已用作确定6例AML患者HSC-B集合中MRD水平的模板。发现BM和/或HSC-B集合中CD34 +前体细胞的几个子集以非常低的频率(<10(-4))存在。 AML患者的所有六个HSC-B集合均通过8色技术显示了MRD,而仅3个通过先前应用的3色方法显示了MRD。 8色技术在有效检测HSC-B的不同CD34 +亚群以及MRD定量分析中显示出令人鼓舞的结果。 MRD的监测应成为HSC-B收集品质量控制的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号